Peter Mac is an integrated cancer research, treatment and education centre. A place where normal days are extraordinary – as are the people we care for.
Peter Mac’s cytosuite team produces around 60,000 chemotherapy and immunotherapy doses onsite each year.
For #WorldPharmacistsDay, Pharmacist Carolina Loureiro da Silva takes us behind the scenes to see the precision and expertise behind every dose.
AI is opening new possibilities in medicine and cancer research.
Two international Peter Mac-led studies involving 5,600+ patients found AI was as good as a human pathologist at a task used to predict breast cancer outcomes.
Read more: petermac.org/about-us/news-a…#BreastCancer#AI
Peter Mac researchers have received almost $1.5 million from @NBCFAus to pursue three bold projects exploring CAR T-cell therapy and treatment resistance in breast cancer.
Read more: petermac.org/about-us/news-a…
As cancer rates rise, so too does survival.
New research projects 2.6 million Australians will be living with a cancer diagnosis by 2050.
Prof Michael Jefford says stronger systems will be needed for survivors’ long-term health and wellbeing.
More: petermac.org/about-us/news-a…
Peter Mac researchers from @shomgoel's lab have uncovered why breast cancer treatment stops working for some patients.
Published in @Nature, the discovery could help develop new treatment combinations that work for longer and improve outcomes.
More: petermac.org/about-us/news-a…
Congratulations to Peter Mac Clinician Scientist A/Prof @shomgoel on receiving the 2026 Robert Sutherland Award for Excellence in Translational Research from @BreastCancerTrials.
More: petermac.org/about-us/news-a…
Associate Professor David Liu is leading a new study that could change how stomach and oesophageal cancers are detected and treated after surgery.
Read more: petermac.org/about-us/news-a…
More than half of our DNA comes from ancient viruses.
Peter Mac research has uncovered new insights into how cells keep these viral sequences silent, revealing potential new ways to harness the body's own antiviral response against cancer.
Read more: petermac.org/about-us/news-a…
Three Peter Mac researchers have secured a combined $3.6M from @NBCFAus to advance bold new approaches to breast cancer prevention and treatment.
Congratulations @parkerlabPMCC Parker, @slaney_clare and Professor Christobel Saunders.
More: petermac.org/about-us/news-a…
New research from Peter Mac has uncovered further evidence of how pregnancy triggers a powerful, long-lasting immune response in the breast, opening the door to potential new ways to prevent #breastcancer in people at high risk.
Read more: petermac.org/about-us/news-a…
Cancer treatment breakthroughs start with better data.
Dr @DrLizChristie HARMONY study, backed by a nearly $3M MRFF grant, will unlock how cancers respond to and resist treatment - driving more personalised care.
More: petermac.org/about-us/news-a…
For two decades, the @VicCancBiobank has been powering breakthroughs by transforming patient donations into new discoveries.
More than 42K Victorians have generously donated blood and tissue samples, including almost 19,000 patients at Peter Mac.
More: petermac.org/about-us/news-a…
Researchers at Peter Mac's Centre of Health Services Research in Cancer and @NCICancer have developed a digital tool that can rapidly and accurately identify a potentially serious side effect of immunotherapy.
More: petermac.org/about-us/news-a…
Peter Mac research using fruit flies found tumour growth can be switched on or off depending on whether a protein called Chinmo was active - helping reveal that cancer development isn’t just about mutations, but also the environment around them.
More: petermac.org/about-us/news-a…
A Peter Mac-led clinical trial has shown a potent and precisely targeted form radiotherapy, known as SABR, can cure many patients with inoperable kidney cancers.
Read more: petermac.org/about-us/news-a…
Today, on #InternationalNursesDay, we celebrate the extraordinary nurses at Peter Mac and beyond.
Our #nurses provide some of the most specialised cancer care in the world - constantly pushing the boundaries of what exceptional cancer care looks like.
🧠 New from Peter Mac: a web-based program (eReCog) is showing promising results for lymphoma survivors experiencing 'chemo brain' with promising results on processing speed and strong patient engagement.
doi.org/10.1002/pon.70469#CancerResearch#Lymphoma#ChemoBrain
Peter Mac is set to become the first centre to treat a patient under a new PBS-funded CAR T-cell therapy program for multiple myeloma — marking a major step forward for patients with limited options.
More: petermac.org/about-us/news-a…